Mrs Angela Allison Tinson, OTR/L, CHT | |
2039 Forest Ave, 104, San Jose, CA 95128-4817 | |
(408) 279-8501 | |
(408) 279-8504 |
Full Name | Mrs Angela Allison Tinson |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 25 Years |
Location | 2039 Forest Ave, San Jose, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053607374 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XH1200X | Occupational Therapist - Hand | 6589 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Barman And Sargent Inc | 2163317025 | 14 |
News Archive
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
A study of nearly 400 people finds that those who exhibited more 'dispositional mindfulness', or awareness of and attention to their current feelings and thoughts, were less likely to be obese and had less abdominal fat than people who did not exhibit as much of that awareness.
› Verified 4 days ago
Provider Name | Barman & Sargent Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1225156524 PECOS PAC ID: 2163317025 Enrollment ID: O20040218001197 |
News Archive
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
A study of nearly 400 people finds that those who exhibited more 'dispositional mindfulness', or awareness of and attention to their current feelings and thoughts, were less likely to be obese and had less abdominal fat than people who did not exhibit as much of that awareness.
› Verified 4 days ago
Provider Name | Peninsula Hand Therapy, Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1750409561 PECOS PAC ID: 2264425842 Enrollment ID: O20040407001583 |
News Archive
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
A study of nearly 400 people finds that those who exhibited more 'dispositional mindfulness', or awareness of and attention to their current feelings and thoughts, were less likely to be obese and had less abdominal fat than people who did not exhibit as much of that awareness.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Angela Allison Tinson, OTR/L, CHT 1450 Veterans Blvd, Ste 110, Redwood City, CA 94063-2619 Ph: (408) 733-3670 | Mrs Angela Allison Tinson, OTR/L, CHT 2039 Forest Ave, 104, San Jose, CA 95128-4817 Ph: (408) 279-8501 |
News Archive
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
A study of nearly 400 people finds that those who exhibited more 'dispositional mindfulness', or awareness of and attention to their current feelings and thoughts, were less likely to be obese and had less abdominal fat than people who did not exhibit as much of that awareness.
› Verified 4 days ago
Marjereen Mirabueno, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 459 Mignot Ln, San Jose, CA 95111 Phone: 650-814-0720 | |
Mrs. Judith Wolf Ivan, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5998 Pilgrim Ave, San Jose, CA 95129 Phone: 408-252-9086 | |
Liza Bacal, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 N 13th St, San Jose, CA 95112 Phone: 408-295-2665 | |
Alyshia Ayn Abraham, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1327 Hillcrest Dr, San Jose, CA 95120 Phone: 408-649-5745 | |
Jerilyn Smith, OTR SWC Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Las Colinas Ln, San Jose, CA 95119 Phone: 408-284-2812 Fax: 408-284-2875 | |
Miss Mary-lynn Zweers, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2001 The Alameda, San Jose, CA 95126 Phone: 408-261-7777 Fax: 408-259-2273 | |
Patricia Pham Tran, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 556 N 1st St Ste 201, San Jose, CA 95112 Phone: 408-384-4993 Fax: 408-856-1246 |